9/5/2023 | BKHY | Moody's assigns B3 to Kedrion
|
4/17/2023 | BKHY | S&P gives B to Kevlar, loan, notes
|
4/17/2023 | BKHY | Moody's rates Kevlar, loan, notes B3
|
9/6/2022 | HYLM | Italy’s Kedrion redeems 3 3/8% senior secured notes due 2026
|
4/12/2022 | HYLM | Italy’s Kedrion calls for early redemption all 3% notes due in July
|
1/24/2022 | BKHY | S&P revises Kedrion view to stable
|
12/17/2021 | BKHY | Moody's downgrades Kedrion
|
4/30/2021 | HY | New Issue: Kedrion prices €410 million 3 3/8% five-year secured notes at par
|
4/28/2021 | HY | Kedrion talks €410 million five-year secured notes in high 3% area
|
4/27/2021 | HY | Italy-based Kedrion selling €410 million five-year secured notes
|
4/27/2021 | BKHY | S&P rates Kedrion, loan, notes B
|
4/26/2021 | BKHY | Moody's assigns to Kedrion, notes B1
|
7/5/2017 | HY | Market Commentary: Domestic primary sphere remains on hold, activity seen in Europe; energy issues off as crude surge snapped
|
7/5/2017 | HY | Market Commentary: Domestic primary sphere remains on hold, activity seen in Europe; energy issues off as crude surge snapped
|
7/5/2017 | BKCVDDEMIGPV | Market Commentary: Domestic primary on hold, activity seen in Europe; energy issues off as crude surge ends
|
7/5/2017 | HY | New Issue: Italy’s Kedrion prices upsized €350 million 3% five-year notes at 99.43 to yield 3 1/8%
|
7/5/2017 | HYLM | Italy’s Kedrion gets tenders for €91.08 million of 4.625% notes
|
6/27/2017 | EULM | Italy’s Kedrion tenders for €300 million of 4.625% notes due 2019
|
9/21/2015 | EULM | Kedrion begins tender offer for €100 million of 4.625% notes due 2019
|
6/29/2006 | BT | Nabi Biopharmaceuticals, Kedrion to develop Civacir in hepatitis C
|